Last reviewed · How we verify

NCT03723018

Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors

Completed NA Last updated 9 June 2021
What this trial tests

NA trial testing Meditation in Genetic Counseling Profession in 605 participants. Completed in 14 May 2021.

Timeline
5 September 2019
Primary endpoint
11 January 2021
14 May 2021

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment605
Start date5 September 2019
Primary completion11 January 2021
Estimated completion14 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Eligibility, any sex, with Genetic Counseling Profession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to determine whether meditation is beneficial for genetic counselors and genetic counseling students. The main goal is to see if meditation can help with professional well-being (burnout for genetic counselors, stress for genetic counseling students). The investigators will also explore whether meditation has other benefits for the genetic counseling profession.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Contributors to and consequences of burnout among clinical genetic counselors in the United States.
    Caleshu C, Kim H, Silver J, Austin J, et al · · 2022 · cited 26× · PMID 34318970 · DOI 10.1002/jgc4.1485

Verify or expand the search:

Other trials of Meditation

Trials testing the same drug.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03723018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing